We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
Price loading...
Springer Platinum and Other Metal Coordination Compounds in Cancer Chemotherapy
Price data last checked 132 day(s) ago - refreshing...
Price History & Forecast
No Price Data Available
Price history will appear here once data is collected from Amazon.
Price Distribution
No price data available for histogram
Description
Taken together the data presented in this review, and work by many other investigators, support the notion that DNA excision repair is important in a tumor cell's resistance to platinum compounds. Inhibition of this repair system by combination chemotherapy with the excision repair inhibitors HU and Ara-C produces synergistic cell kills and increased levels and persistance of DNA interstrand crosslinks. The studies with cis-DDP and ~-DDP in combination with UV induced thymine dimers suggest that there may be competition for DNA repair enzymes between the dimer and the platinum lesion. Whether the competing lesion is an intrastrand crosslink, interstrand crosslink, or platinum monoadduct (or all of these lesions) cannot be determined. The similarity between an intrastrand crosslink and a cyclobutane dimer suggests that these lesions may compete for repair. However, the increased peak levels of interstrand crosslinks, and increased persistence of these lesions at later time points suggest that this lesion may also be a substrate for the repair system. These observations may be of clinical relevance. Recently Dr. Kathy Albain of our institution has completed a Phase III I study using a 12 hour pretreatment with HU and Ara-C in patients prior to their cis-DDP therapy. She observed a significant number of responders in this trial (54). She is currently completing a second Phase IIII study substituting IV HU for the oral formulation. We anticipate initiating other clinical trials based upon these observations.
Product Specifications
- Brand
- Springer
- Format
- paperback
- ASIN
- 1489907408
- Domain
- Amazon UK
- Release Date
- 19 June 2013
- Listed Since
- 07 November 2013
Barcode
No barcode data available
Similar Products You Might Like
96% match
PARP Inhibitors for Cancer Therapy (Cancer Drug Discovery and Development)
Humana
£112.83
01 Mar 2026
96% match
Concepts, Mechanisms, and New Targets for Chemotherapy: 78 (Cancer Treatment and Research, 78)
Springer
£149.64
19 Apr 2026
96% match
Humana DNA Damage and Repair - Contemporary Cancer Research
Humana
£113.76
19 Apr 2026
96% match
New Drugs, Concepts and Results in Cancer Chemotherapy: 58 (Cancer Treatment and Research, 58)
Springer
£113.48
19 Apr 2026
95% match
Molecular and Clinical Advances in Anticancer Drug Resistance: 57 (Cancer Treatment and Research, 57)
Springer
£165.95
09 Apr 2026
95% match
Molecular and Clinical Advances in Anticancer Drug Resistance: 57 (Cancer Treatment and Research, 57)
Springer
£148.69
13 Jan 2026
95% match
Cancer: Principles and Practice of Oncology Primer of Molecular Biology in Cancer
WOLTERS KLUWER HEALTH
£55.30
06 Feb 2026
95% match
Springer Advances in Molecular Oncology: 604 - Science Book
Springer
£105.11
24 Feb 2026
95% match
Wiley Anticancer Therapeutics - Oncology Drug Design Book
Wiley
£133.27
15 Apr 2026
95% match
Cancer Chemotherapy and Selective Drug Development: Proceedings of the 10th Anniversary Meeting of the Coordinating Committee for Human Tumour ... 24–28, 1983: 23 (Developments in Oncology)
Springer
£129.02
11 Apr 2026
95% match
Advances in Cancer Research: v. 87: Vol. 87: Volume 87
Academic Press
£88.19
09 Mar 2026
95% match
Molecular Biology of Human Cancers
£96.11
13 Jan 2026
95% match
Anticancer Genes: 818 (Advances in Experimental Medicine and Biology, 818)
Springer
£61.40
15 Apr 2026
95% match
The Chemistry of Antitumour Agents
Springer
£41.15
13 Apr 2026
95% match
Improving the Therapeutic Ratio in Head and Neck Cancer (Volume 6) (Cancer Sensitizing Agents for Chemotherapy, Volume 6)
Academic Press
£111.19
10 Mar 2026
95% match
Clinical Evaluation of Antitumor Therapy: 46 (Developments in Oncology, 46)
Springer
£146.40
25 Jan 2026
95% match
Anti-Cancer N-Heterocyclic Carbene Complexes of Gold(III), Gold(I) and Platinum(II): Thiol “Switch-on” Fluorescent Probes, Thioredoxin Reductase ... Reticulum Targeting Agents (Springer Theses)
Springer
£74.72
08 Mar 2026
95% match
Free-Radical-Induced DNA Damage and Its Repair: A Chemical Perspective
Springer
£180.00
15 Dec 2025
95% match
Springer Molecular Basis of Human Cancer - NATO Science Series
Springer
£121.37
24 Feb 2026
95% match
Handbook of Research on Advancements in Cancer Therapeutics (Advances in Medical Diagnosis, Treatment, and Care)
£418.38
11 Jan 2026
95% match
Molecular Oncology: Underlying Mechanisms and Translational Advancements
Springer
£82.73
09 Mar 2026
95% match
Towards Dual and Targeted Cancer Therapy with Novel Phthalocyanine-based Photosensitizers (Springer Theses)
Springer
£75.84
01 Mar 2026
95% match
Advances in Cancer Research: 97 (Advances in Cancer Research): Volume 97
Academic Press
£64.11
28 Feb 2026
95% match
Advances in Cancer Research: 77: Volume 77
Academic Press
£90.19
08 Mar 2026